Fatty acid ω- and (ω-1)-hydroxylation in experimental alcoholic liver disease: Relationship to different dietary fatty acids

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 7, 1998, Pages 1493-1500

  Amet, Yolande ^a   Adas, Fadi ^a   Nanji, Amin A ^b,c  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Arachidonic Acid; CYP2E1; CYP4A; Ethanol; Fatty Acids

Indexed keywords

LINOLEIC ACID;

ALCOHOL LIVER DISEASE; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; DISEASE SEVERITY; FAT INTAKE; FATTY ACID METABOLISM; HYDROXYLATION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031725529     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03941.x     Document Type: Article

References (57)

1. Reitz RC: The effects of ethanol on lipid metabolism. Prog Lipid Res 18:87-115, 1978
2. French SW, Ihrig TJ, Morin RJ: Lipid composition of RBC, liver mitochondria and microsomes of ethanol-fed rats. J Stud Alcohol 31:801-809, 1970
3. Cairns SR, Peters TJ: Biochemical analysis of hepatic lipid in alcoholic and diabetic subjects. Clin Sci 65:645-652, 1983
4. Nanji AA, Sadrzadeh SMH, Dannenberg AJ: Liver microsomal fatty acid composition in ethanol-fed rats: Effect of different dietary fats and relationship to liver injury. Alcohol Clin Exp Res 18:1024-1028, 1994
5. Needleman P, Turk J, Takschik BA, Takschik, Morrison AR, Lefkowith JB: Arachidonic acid metabolism. Annu Rev Biochem 55:62-102, 1986
6. Smith WL: Prostanoid biosynthesis and mechanism of action. Am J Physiol 263:383-417, 1992
7. McGiff JC: Cytochrome P450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 31:339-369, 1991
8. Capdevila JH, Falck JR, Estabrook RW: Cytochrome P450 and the arachidonate cascade. FASEB J 6:731-736, 1992
9. Oliw EH: Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog Lipid Res 33:329-354, 1994
10. Sharma DK, Doig MV, Lewis DFW, Gibson G: Role of hepatic and renal cytochrome P450 IVA1 in the metabolism of lipid substrates. Biochem Pharmacol 38:3621-3629, 1989
11. Rifkind AB, Lee C, Chang TKH, Waxman DJ: Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1 and 1A2: Regioselective oxygenation and evidence for a role for CYP 2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 320:380-389, 1995
12. Clarke SE, Baldwin SJ, Bloomer JC, Ayrton AD, Sozio RS, Chenery RJ: Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem Res Toxicol 7:836-842, 1994
13. Capdevila JH, Zeldin D, Makita K, Karara A, Falck JR: Cytochrome P450 and the metabolism of arachidonic acid and oxygenated eicosanoids, in Ortiz de Montellano P (ed): Cytochrome P450: Structure, Mechanism and Biochemistry. New York, Plenum Press, 1995, pp 443-471
14. Makita K, Falck JR, Capdevila JH: Cytochrome P450, the arachidonic acid cascade and hypertension: New vistas for an old enzyme system. FASEB J 10:1456-1463, 1996
15. Amet Y, Berthou F, Goasduff T, Salaun JP, Le Breton L, Menez JF: Evidence that cytochrome P450 2E1 is involved in the (ω-1) hydroxylation of lauric acid in rat liver microsomes. Biochem Biophys Res Commun 203:1168-1174, 1994
16. Amet Y, Berthou S, Baird S, Dreano Y, Bail JP, Menez JF: Validation of the (ω-1)-hydroxylation of lauric acid as an in vitro substrate for human liver CYP 2E1. Biochem Pharmacol 50:1775-1782, 1995
17. Capdevila JH, Falck JR, Estabrook RW: Cytochrome P450 and the arachidonic acid cascade. FASEB J 6:731-736, 1992
18. French SW, Miyamoto K, Tsukamoto H: Ethanol-induced hepatic fibrosis in the rat: Role of the amount of dietary fat. Alcohol Clin Exp Res 10:13S-19S, 1986
19. Tsukamoto H, Gaal K, French SW: Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: Status report. Hepatology 12:599-608, 1990
20. Nanji AA, Mendenhall CL, French WW: Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 13:15-19, 1989
21. Nanji AA, French SW: Dietary linoleic acid is required for development of experimental alcoholic liver disease. Life Sci 44:223-227, 1989
22. Nanji AA, Khwaja S, Tahan SR, Sadrzadeh SMH: Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlates with the severity of liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther 269:1280-1285, 1994
23. Takahashi H, Johansson I, French SW, Ingelman-Sundberg M: Effect of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrome P450 (CYP 2E1) in the liver of rats chronically fed ethanol. Pharmacol Toxicol 70:347-352, 1992
24. Yoo JSH, Hong JY, Ning SM, Yang CS: Roles of dietary corn oil in the regulation of cytochromes P450 and glutathione-S-transferases in rat liver. J Nutr 120:1718-1726, 1990
25. Yoo JSH, Ning SM, Pautuck CB: Regulation of hepatic microsomal cytochrome P450 2E1 by dietary lipids and carbohydrates in rats. J Nutr 121:959-965, 1991
26. Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M, Dannenberg AJ: Dietary saturated fatty acids: A novel treatment for alcoholic liver disease. Gastroenterology 109:547-555, 1995
27. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR, Dannenberg AJ: Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112:943-951, 1997
28. Berthou F, Ratanasavanh D, Riché C, Picart D, Voirin T, Guillouzo A: Comparison of caffeine metabolism by slices, microsomes and hepatocyte cultures from adult human liver. Xenobiotica 19:401-417, 1989
29. Bradford M: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
30. Peter R, Böcker R, Beaune P, Iwasaki M, Guengerich P, Yang CS: Hydroxylation of chlorozoxazone as a specific probe for human liver cytochrome P450 2E1. Chem Res Toxicol 3:566-573, 1990
31. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, Berthou F: Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857, 1993
32. Koop DR: Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450. Mol Pharmacol 29:399-404, 1986
33. Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO: Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP 2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol 46:1975-1981, 1993
34. Amet Y, Berthou F, Ménez JF: Simultaneous radiometric and fluorimetric detection of lauric acid metabolites using high-performance liquid chromatography following esterification with 4-bromomethyl-6,7-dimethoxycoumarin. J Chromatog B 681:233-239, 1996
35. Laemmli UK: Change of structural proteins during the assembly of bacteriophage T4. Nature 227:680-685, 1970
36. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
37. Nanji AA, Griniuviene B, Sadrzadeh SMH, Levitsky S, McCully JD: Effect of type of dietary fat and ethanol on antioxidant enzyme mRNA induction in the rat. J Lipid Res 36:736-744, 1995
38. Nanji AA, Zhao S, Lamb RG, Dannenberg AJ, Sadrzadeh SMH, Waxman DJ: Changes in cytochrome P450 2E1, 2B, 4A, phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: Relationship to dietary fats and pathologic liver injury. Alcohol Clin Exp Res 18:902-908, 1994
39. Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR, Waxman DJ: Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol fed rats. Alcohol Clin Exp Res 18:1280-1285, 1994
40. Nanji AA, Dannenberg AJ, Bass NM: Dietary fat composition influences cell injury in experimental alcoholic liver disease and has divergent effects on the expression of liver fatty acid binding protein and enzymes of extramitochondrial fatty acid oxidation. Gastroenterology 110: A1274, 1996
41. French SW, Morimoto M, Reitz RC, Koop D, Klopfenstein B, Estes K, Clot P, Ingelman-Sundberg M, Albano E: Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats. J Nutr 127:9075-9115, 1997
42. Nanji AA, Zhao S, Lamb RG, Sadrzadeh SMH, Dannenberg AJ, Waxman DJ: Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: Relationship to cytochrome P450 2E1 induction and conjugated diene formation. Alcohol Clin Exp Res 17:598-603, 1993
43. Ockner RK, Kaikaus RM, Bass NM: Fatty acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis. Hepatology 18:669-676, 1993
44. Schoojans K, Staels B, Auwerx J: Role of peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925, 1996
45. Lock EA, Mitchell AM, Elcombe CR: Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29:145-163, 1989
46. Keller H, Wahli W: Peroxisome proliferator activated receptor and lipid metabolism. Ann NY Acad Sci 684:157-173, 1993
47. Morimoto M, Hagbjork AL, Wan YY, Fu PC, Clot P, Albano E, Ingelman-Sundberg M, French SW: Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibition. Hepatology 21:1610-1617, 1995
48. Tsutsumi M, Lasker J, Shimizu M, Rosman A, Lieber CS: The intralobular distribution of ethanol-inducible P450 2E1 in rat and human liver. Hepatology 10:437-446, 1989
49. Pan J, Hong JY, Ma BL, Ning SM, Paranawithana SR, Yang CS: Transcriptional activation of cytochrome P450 2B genes in rat liver by diallylsulfide, a compound derived from garlic. Arch Biochem Biophys 302:337-342, 1993
50. Harder DR, Campbell WB, Roman AJ: Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vase Res 32:79-92, 1995
51. Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, McGiff JC: Cytochrome P450-dependent HETEs: Profile of biological activity and stimulation by vasoactive peptides. Am J Physiol 271:R863-R869, 1996
52. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, Roman RJ: 20-Hydroxyelcosatetraenoic acid is an endogenous vasoconstrictor of canine renal accurate arteries. Circ Res 72:126-136, 1993
53. Nanji AA, Zakim D: Alcoholic liver disease, in Zakim D, Boyer TD (eds): Hepatology: A Textbook of Liver Disease, ed 3. Philadelphia, WB Saunders, 1996, pp 891-961
54. Escalante B, Sessa WC, Falck JR, Yuclagiri P, Schwartzman ML: Vasoactivity of 20-hydroxyelcosatetraenoic acid is dependent on metabolism by cyclooxygenase. J Pharmacol Exp Ther 248:229-232, 1989
55. Carroll MA, Balazy M, Huang DD, Rybalova S, Falck JR, McGiff JC: Cytochrome P450-derived renal HETEs: Storage and release. Kidney Int 51:1696-1702, 1997
56. Ma X, Baraona E, Lieber CS: Alcohol consumption, enhances fatty acid ω-oxidation with a greater increase in male than in female rats. Hepatology 18:1247-1253, 1993
57. Iimuro Y, Frankenberg MV, Arteel GE, Bradford BU, Wall CA, Thurman RG: Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males. Am J Physiol 272:G1186-G1194, 1997